Viveve Medical logo

Viveve Medical(OTC) VIVE

Market Cap$2.10KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1992)-100%
5 Year-100%
1 Year+100%
1 Month+0%
$0.00
+0.00%
+0.00Today
Viveve Medical last closing stock price
MetricPriceDate
Last closeUSD 0.002026-09-15
Viveve Medical stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-09-08
1 month+0%USD 0.002026-08-13
3 month+0%USD 0.002026-06-17
Year to date+100%USD 0.002025-12-31
1 year+100%USD 0.002025-09-12
3 year-88.24%USD 0.002023-09-15
5 year-99.99%USD 2.342021-09-16
Since inception-100%USD 4,400,000.001992-06-15

Viveve Medical Financials at a Glance

Market Cap

$2.10KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$6.83M

Net Income (TTM)

-$23.92M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-76.16 (Low)

Price

$0.00

Volume

100

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Aug 31, 2026

VIVE News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Viveve Medical

Viveve Medical, Inc. is a healthcare-focused company that develops innovative medical devices and software solutions aimed at enhancing patient care and operational efficiency. Founded in 2005 and headquartered in Englewood, Colorado, the company specializes in providing advanced technologies for healthcare organizations.

Products and Services
  • Innovative medical devices for women's health and wellness
  • Healthcare-focused human resources software solutions
  • All-in-one platform for recruitment and employee management
Growth Outlook
  • Recent quarterly revenue of $1.68 million shows potential for growth
  • Strong cash position with $5.9 million in cash and equivalents
  • Current ratio of 4.91 indicates solid short-term financial health
Financial Highlights
  • Trailing twelve months revenue of $6.3 million reflects steady performance
  • Net income for Q3 2022 was -$5.29 million, indicating ongoing investment in growth
  • Operating cash flow for Q3 2022 was -$3.35 million, highlighting operational challenges
Viveve Medical, Inc. operates in the medical devices industry, focusing on innovative solutions that address critical healthcare needs. The company has made significant strides in developing products that enhance patient care, particularly in women's health. The recent quarterly revenue indicates a positive trend, suggesting that the company is on a path to recovery and growth. The financial position of Viveve Medical is bolstered by a strong cash reserve, which provides the necessary liquidity to support ongoing operations and future investments. The current ratio of 4.91 is a strong indicator of the company's ability to meet short-term obligations, reflecting a solid financial foundation. Despite reporting a net loss in the most recent quarter, the company's commitment to research and development is evident. This investment is crucial for long-term growth and innovation in a competitive market. The operating cash flow challenges highlight the need for continued focus on operational efficiency and revenue generation. Overall, Viveve Medical, Inc. presents an intriguing opportunity for investors interested in the healthcare sector, particularly in companies that are innovating to improve patient outcomes and operational efficiencies.
AI Generated • Aug 20, 2026

Industry

Healthcare Equipment and Supplies

Employees

47

CEO

Scott C. Durbin

Headquarters

Englewood, CO 80112, US

VIVE Financials

Key Financial Metrics (TTM)

Gross Margin

9.65%

Operating Margin

-335.40%

Net Income Margin

-342.78%

Return on Equity

-199.88%

Return on Capital

-105.57%

Return on Assets

-85.00%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.10KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

10.72M

Volume

100

Avg. Volume

938.968

Financials (TTM)

Gross Profit

$1.12M

Operating Income

-$21.14M

EBITDA

-$20.43M

Operating Cash Flow

-$16.23M

Capital Expenditure

-$595.00K

Free Cash Flow

-$16.83M

Cash & ST Invst.

$5.91M

Total Debt

$5.88M

Viveve Medical Performance Analysis

Viveve Medical annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 6,426,000N/A
Viveve Medical sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42021-12-315.6%
Q12022-03-31-3.8%
Q22022-06-309.4%
Q32022-09-30-6.2%
Viveve Medical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -2.65N/A
Viveve Medical sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42021-12-31-14.5%
Q12022-03-317.9%
Q22022-06-30N/A
Q32022-09-3013.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2022YOY CHG

Revenue

$1.68M

+4.2%

Gross Profit

$546.00K

+378.9%

Gross Margin

32.42%

N/A

Market Cap

$2.10KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$44.68

N/A

Employees

47

N/A

Net Income

-$5.29M

+9.7%

EBITDA

-$4.51M

+15.3%

Quarterly Fundamentals

Name
Q3 2022YOY CHG

Total Cash

$5.91M

-73.9%

Total Debt

$5.88M

+13.6%

Accounts Receivable

$860.00K

+67.3%

Inventory

$1.62M

-24.9%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$5.88M

+2648.1%

Return on Assets

-85.00%

N/A

Return on Invested Capital

-1.01%

N/A

Free Cash Flow

-$3.54M

-29.0%

Operating Cash Flow

-$3.35M

-25.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TNGNQTengion, Inc.
$0.00+0.00%
NMRDNemaura Medical Inc.
$0.00+0.00%
KLDOKaleido Biosciences, Inc.
$0.00+0.00%
BXRXQBaudax Bio, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
MEDSDataMEDS Ai
$6.07+274.69%
AALAmerican Airlines Group
$12.70-0.55%
NOKNokia
$10.14+3.05%
INTCIntel
$101.05+4.03%

Questions About VIVE

What is the current price of Viveve Medical?

Viveve Medical is trading at $0.00 per share.

What is the 52-week range for Viveve Medical?

Over the past 52 weeks, Viveve Medical has traded between $0.00 and $0.00.

How much debt does Viveve Medical have?

As of the most recent reporting period, Viveve Medical reported total debt of $5.68M.

How much cash does Viveve Medical have on hand?

Viveve Medical reported $19.16M in cash and cash equivalents in its most recent financial results.

What is Viveve Medical’s dividend yield?

Viveve Medical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.